Conference Paper: Long-term outcomes of entecavir monotherapy after liver transplantation for hepatitis B: 5 years data

TitleLong-term outcomes of entecavir monotherapy after liver transplantation for hepatitis B: 5 years data
Authors
Issue Date2015
Citation
The 21st Annual International Congress of the International Liver Transplantation Society (ILTS 2015), Chicago, IL., 8-11 July 2015. How to Cite?
AbstractBACKGROUND: Previous study has shown that entecavir monotherapy is effective and safe to prevent hepatitis B (HBV) recurrence after liver transplantation (LT) but long-term data is lacking. The aim of the current study is to review the long-term results of entecavir monotherapy in HBV patients after LT ...
DescriptionOral Abstract Session: HEPATITIS B/C: no. O-55
Persistent Identifierhttp://hdl.handle.net/10722/217508

 

DC FieldValueLanguage
dc.contributor.authorWong, CLT-
dc.contributor.authorFung, JYY-
dc.contributor.authorChan, MY-
dc.contributor.authorChok, KSH-
dc.contributor.authorCheung, TT-
dc.contributor.authorChan, ACY-
dc.contributor.authorDai, WC-
dc.contributor.authorChan, SC-
dc.contributor.authorLo, CM-
dc.date.accessioned2015-09-18T06:01:18Z-
dc.date.available2015-09-18T06:01:18Z-
dc.date.issued2015-
dc.identifier.citationThe 21st Annual International Congress of the International Liver Transplantation Society (ILTS 2015), Chicago, IL., 8-11 July 2015.-
dc.identifier.urihttp://hdl.handle.net/10722/217508-
dc.descriptionOral Abstract Session: HEPATITIS B/C: no. O-55-
dc.description.abstractBACKGROUND: Previous study has shown that entecavir monotherapy is effective and safe to prevent hepatitis B (HBV) recurrence after liver transplantation (LT) but long-term data is lacking. The aim of the current study is to review the long-term results of entecavir monotherapy in HBV patients after LT ...-
dc.languageeng-
dc.relation.ispartofAnnual International Congress of the International Liver Transplantation Society, ILTS 2015-
dc.rightsCreative Commons: Attribution 3.0 Hong Kong License-
dc.titleLong-term outcomes of entecavir monotherapy after liver transplantation for hepatitis B: 5 years data-
dc.typeConference_Paper-
dc.identifier.emailWong, CLT: wongtcl@hku.hk-
dc.identifier.emailFung, JYY: jfung@hkucc.hku.hk-
dc.identifier.emailChok, KSH: chok6275@hku.hk-
dc.identifier.emailCheung, TT: cheung68@hku.hk-
dc.identifier.emailChan, ACY: acchan@hku.hk-
dc.identifier.emailDai, WC: daiwc@hku.hk-
dc.identifier.emailChan, SC: chanlsc@hkucc.hku.hk-
dc.identifier.emailLo, CM: chungmlo@hkucc.hku.hk-
dc.identifier.authorityWong, CLT=rp01679-
dc.identifier.authorityFung, JYY=rp00518-
dc.identifier.authorityChok, KSH=rp02110-
dc.identifier.authorityChan, ACY=rp00310-
dc.identifier.authorityChan, SC=rp01568-
dc.identifier.authorityLo, CM=rp00412-
dc.description.naturepostprint-
dc.identifier.hkuros251768-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats